Project Grant H8E37761

This $2,130,996 Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) program supports public health activities by the District of Columbia Department of Health (DC Health). Key products and services to be delivered through this five-year award (Aug 2024 - Jul 2029) include: Enhancing epidemiological surveillance and disease reporting capabilities through transitioning to an internal data...

This federal Cooperative Agreement award was made by the Centers for Disease Control and Prevention (CDC) under the Investigations and Technical Assistance program (CFDA 93.283). The $13,207,566 award, with a start date of August 1, 2024 and a completion date of July 31, 2029, is titled "NYS/HRI EPIDEMIOLOGY AND LABORATORY CAPACITY FOR PREVENTION AND CONTROL OF EMERGING INFECTIOUS DISEASES (ELC)". The primary awardee, Health Research, Inc., will use the funding to provide a range of...

Numentus Technologies Inc. received a $303,685 Project Grant award from the National Science Foundation on February 15, 2021 to develop rapid planar PCR technology for COVID-19 testing. The award was made under the NSF's Engineering program (CFDA 47.041) to support innovation and excellence in engineering research. Through this funding, Numentus will work to advance the development of planar PCR, a technology that enables highly sensitive COVID-19 detection on a single integrated testing...

This National Science Foundation (NSF) Engineering program (CFDA 47.041) project grant award to the Rector & Visitors of the University of Virginia (University of Virginia) provides $251,493 to develop optimized pooled testing strategies for efficient COVID-19 prevalence tracking and accurate virus diagnostic testing. The project aims to overcome limitations of traditional group testing methods by designing advanced pooled testing approaches with strong theoretical performance guarantees yet...

This $968,765 Project Grant awarded by the National Science Foundation's (NSF) Division of Mathematical Sciences (CFDA 47.049 - Mathematical and Physical Sciences) will develop a flexible modeling framework to simulate the impact of various testing-based infection control strategies for respiratory pathogens like SARS-CoV-2. The project aims to improve our ability to control existing respiratory diseases and enhance preparedness for future pandemics. Key deliverables include: Developing a...

The Federated States of Micronesia (FSM) Department of Health and Social Affairs has received a $505,746 Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) program (CFDA 93.323). The grant will fund a five-year project from August 1, 2024 to July 31, 2029 to enhance the department's capacity for detecting, responding to, preventing, and controlling infectious diseases across the...

The National Science Foundation awarded a $220,000 Project Grant to the University of Connecticut under the Engineering (47.041) federal grant program. The award will fund development of a compact, field-portable biophotonics instrument for automated analysis and identification of blood cells impacted by COVID-19. The instrument aims to provide real-time sensing and diagnosis capabilities with high accuracy, specificity and sensitivity for potential early detection of COVID-19 infections. It...

This Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Epidemiology and Laboratory Capacity for Infectious Diseases (CFDA 93.323) program provides $2,048,852 to the Ohio Department of Health (ODH) to build and strengthen epidemiology, laboratory, and health information systems for detecting, responding to, preventing, and controlling known and (re-)emerging infectious diseases in Ohio. The award supports ODH's work with 111 local health departments...

The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $40.4 million cooperative agreement to Exela Pharma Sciences, LLC (Exela) to expand industrial base capabilities for COVID-19 response. With a period of performance from May 2022 through May 2034, this cooperative agreement will support Exela under the Research on Chemical and Biological Defense program (CFDA 12.360). Through this cooperative agreement, Exela will further the government's...

DPX Technologies LLC received a $254,536 Project Grant award from the National Science Foundation to develop high-throughput COVID-19 testing under the SBIR PHASE I program. The award, provided by NSF's Directorate for Engineering between April 1, 2021 and September 30, 2021, aims to foster innovation in engineering research and development under the Engineering (47.041) federal grant program. Specifically, DPX Technologies will leverage the funding to create products and services focused on...